Eric M. Bonnem

1.3k total citations
35 papers, 934 citations indexed

About

Eric M. Bonnem is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Eric M. Bonnem has authored 35 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Eric M. Bonnem's work include Chronic Lymphocytic Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Eric M. Bonnem is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Multiple Myeloma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Eric M. Bonnem collaborates with scholars based in United States, United Kingdom and Switzerland. Eric M. Bonnem's co-authors include A Fefer, J.H. Scarffe, Pamela G. Kidd, John A. Thompson, Jan Kaufmann, D. Crowther, Bruce D. Cheson, L Smallwood, Raymond Alexanian and William P. Steward and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Eric M. Bonnem

35 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric M. Bonnem United States	18	379	344	236	172	149	35	934
Robert H. Rudolph United States	17	263 0.7×	387 1.1×	197 0.8×	118 0.7×	182 1.2×	30	904
Esteban Abella United States	17	512 1.4×	551 1.6×	233 1.0×	178 1.0×	155 1.0×	56	1.3k
H Gerhartz Germany	12	217 0.6×	261 0.8×	161 0.7×	100 0.6×	112 0.8×	42	666
R Powles United Kingdom	19	258 0.7×	645 1.9×	228 1.0×	191 1.1×	124 0.8×	52	1.1k
M. A. Boogaerts Belgium	20	242 0.6×	823 2.4×	232 1.0×	266 1.5×	262 1.8×	29	1.2k
Ronald L. Chard United States	17	185 0.5×	445 1.3×	104 0.4×	147 0.9×	110 0.7×	26	904
N Jamal Canada	17	210 0.6×	607 1.8×	358 1.5×	218 1.3×	237 1.6×	35	1.3k
Eugene M. Berkman United States	14	213 0.6×	360 1.0×	222 0.9×	69 0.4×	92 0.6×	21	758
Jeanne Odom United States	13	412 1.1×	364 1.1×	404 1.7×	95 0.6×	91 0.6×	27	1.1k
D. Kyriakou Greece	21	234 0.6×	368 1.1×	166 0.7×	190 1.1×	133 0.9×	44	872

Countries citing papers authored by Eric M. Bonnem

Since Specialization

Citations

This map shows the geographic impact of Eric M. Bonnem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Bonnem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Bonnem more than expected).

Fields of papers citing papers by Eric M. Bonnem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Bonnem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Bonnem. The network helps show where Eric M. Bonnem may publish in the future.

Co-authorship network of co-authors of Eric M. Bonnem

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Bonnem. A scholar is included among the top collaborators of Eric M. Bonnem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Bonnem. Eric M. Bonnem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bonnem, Eric M., et al.. (1996). Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma. Investigational New Drugs. 14(4). 387–389. 20 indexed citations

Dehmer, Gregory, et al.. (1996). Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.. PubMed. 94(9 Suppl). II347–52. 18 indexed citations

Gilleece, Maria, J.H. Scarffe, A K Ghosh, et al.. (1992). Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections – a phase I dose toxicity trial. British Journal of Cancer. 66(1). 204–210. 47 indexed citations

Golomb, Harvey M., Mark J. Ratain, A Fefer, et al.. (1991). Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients. Leukemia & lymphoma. 5(5-6). 335–340. 2 indexed citations

Bonnem, Eric M.. (1991). Alpha interferon: The potential drug of adjuvant therapy: Past achievements and future challenges. European Journal of Cancer and Clinical Oncology. 27. S2–S6. 8 indexed citations

Golomb, Harvey M., A Fefer, David W. Golde, et al.. (1991). Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B. Leukemia & lymphoma. 4(2). 99–102. 10 indexed citations

Scarffe, J.H., et al.. (1990). Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer. British Journal of Cancer. 61(5). 749–754. 30 indexed citations

Steward, William P., J.H. Scarffe, D. Crowther, & Eric M. Bonnem. (1990). Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor. Stem Cells. 8(S1). 335–346. 9 indexed citations

Thompson, John A., et al.. (1989). Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.. Journal of Clinical Oncology. 7(5). 629–637. 144 indexed citations

10.

Steward, William P., J.H. Scarffe, Robert D. Austin, et al.. (1989). Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions – a phase I dose-toxicity study. British Journal of Cancer. 59(1). 142–145. 68 indexed citations

11.

Dorr, R T, et al.. (1988). Phase I-II Trial of Interferon-α _2b by Continuous Subcutaneous Infusion over 28 Days. Journal of Interferon Research. 8(6). 717–725. 12 indexed citations

12.

Golomb, Harvey M., Mark J. Ratain, A Fefer, et al.. (1988). Randomized Study of the Duration of Treatment With Interferon Alfa-2B in Patients With Hairy Cell Leukemia. JNCI Journal of the National Cancer Institute. 80(5). 369–373. 48 indexed citations

13.

Golomb, Harvey M., A Fefer, David W. Golde, et al.. (1988). Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.. PubMed. 15(5 Suppl 5). 7–9. 38 indexed citations

14.

Bonnem, Eric M.. (1988). The therapy of multiple myeloma with the interferons. Cancer Treatment Reviews. 15. 35–41. 3 indexed citations

15.

Bonnem, Eric M.. (1987). Alfa interferon: combinations with other antineoplastic modalities.. PubMed. 14(2 Suppl 2). 48–53. 29 indexed citations

16.

Berek, Jonathan S., Neville F. Hacker, Alan Lichtenstein, et al.. (1986). Intraperitoneal recombinant α-interferon for “salvage” immunotherapy in stage III epithelial ovarian cancer: A gynecologic oncology group study. Seminars in Oncology. 13(3). 61–71. 13 indexed citations

17.

Berg, Christine D., et al.. (1986). The combined use of interferon and radiotherapy in cancer management.. PubMed. 13(3 Suppl 2). 78–83. 25 indexed citations

18.

Bonnem, Eric M., et al.. (1986). Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.. PubMed. 70(11). 1251–4. 16 indexed citations

19.

Berek, J. S., Neville F. Hacker, Alan Lichtenstein, et al.. (1985). Intraperitoneal immunotherapy of human ovarian carcinoma with recombinant interferon: A phase I toxicity/immunopharmacology study. Gynecologic Oncology. 20(2). 259–259. 5 indexed citations

20.

Luderer, John R., Laurence M. Demers, Eric M. Bonnem, Abdus Saleem, & Graham H. Jeffries. (1976). Elevated Prostaglandin E in Idiopathic Intestinal Pseudo-Obstruction. New England Journal of Medicine. 295(21). 1179–1179. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact